Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Virus-like Particles as Antiviral Vaccine: Mechanism, Design, and Application
Authors
Keywords
-
Journal
BIOTECHNOLOGY AND BIOPROCESS ENGINEERING
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-01-06
DOI
10.1007/s12257-022-0107-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Elicitation of potent SARS-CoV-2 neutralizing antibody responses through immunization with a versatile adenovirus-inspired multimerization platform
- (2022) Christopher Chevillard et al. MOLECULAR THERAPY
- Virus-like particles: a self-assembled toolbox for cancer therapy
- (2022) A. Shahrivarkevishahi et al. Materials Today Chemistry
- Capsid-like particles decorated with the SARS-CoV-2 receptor-binding domain elicit strong virus neutralization activity
- (2021) Cyrielle Fougeroux et al. Nature Communications
- The Role of the Host Ubiquitin System in Promoting Replication of Emergent Viruses
- (2021) Karl M. Valerdi et al. Viruses-Basel
- Phase 1 randomized trial of a plant-derived virus-like particle vaccine for COVID-19
- (2021) Brian J. Ward et al. NATURE MEDICINE
- Recent Applications of Deep Learning Methods on Evolution- and Contact-Based Protein Structure Prediction
- (2021) Donghyuk Suh et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Trivalent Subunit Vaccine Candidates for COVID-19 and Their Delivery Devices
- (2021) Oscar A. Ortega-Rivera et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Development and Evaluation of an Ebola Virus Glycoprotein Mucin-Like Domain Replacement System as a New Dendritic Cell-Targeting Vaccine Approach against HIV-1
- (2021) Zhujun Ao et al. JOURNAL OF VIROLOGY
- An enveloped virus-like particle vaccine expressing a stabilized prefusion form of the SARS-CoV-2 spike protein elicits highly potent immunity
- (2021) Anne-Catherine Fluckiger et al. VACCINE
- Mass Production of Virus-Like Particles Using Chloroplast Genetic Engineering for Highly Immunogenic Oral Vaccine Against Fish Disease
- (2021) Yoichi Nakahira et al. Frontiers in Plant Science
- LZerD Protein-Protein Docking Webserver Enhanced With de novo Structure Prediction
- (2021) Charles Christoffer et al. Frontiers in Molecular Biosciences
- Immunization with Leishmania tarentolae-derived norovirus virus-like particles elicits high humoral response and stimulates the production of neutralizing antibodies
- (2021) Mirosława Panasiuk et al. Microbial Cell Factories
- A multiclade env–gag VLP mRNA vaccine elicits tier-2 HIV-1-neutralizing antibodies and reduces the risk of heterologous SHIV infection in macaques
- (2021) Peng Zhang et al. NATURE MEDICINE
- Two-step purification of tag-free norovirus-like particles from silkworm larvae (Bombyx mori)
- (2021) Jirayu Boonyakida et al. PROTEIN EXPRESSION AND PURIFICATION
- Sequential immunization of macaques elicits heterologous neutralizing antibodies targeting the V3-glycan patch of HIV-1 Env
- (2021) Amelia Escolano et al. Science Translational Medicine
- Bivalent vaccination with NA1 and NA2 neuraminidase virus-like particles is protective against challenge with H1N1 and H3N2 influenza A viruses in a murine model
- (2021) Zach Menne et al. VIROLOGY
- Antigenicity and immunogenicity of HA2 and M2e influenza virus antigens conjugated to norovirus-like, VP1 capsid-based particles by the SpyTag/SpyCatcher technology
- (2021) Suvi Heinimäki et al. VIROLOGY
- Two-Component Nanoparticle Vaccine Displaying Glycosylated Spike S1 Domain Induces Neutralizing Antibody Response against SARS-CoV-2 Variants
- (2021) Linda van Oosten et al. mBio
- GII.P16-GII.2 Recombinant Norovirus VLPs Polarize Macrophages Into the M1 Phenotype for Th1 Immune Responses
- (2021) Ji Cheng Han et al. Frontiers in Immunology
- Expression of Chimeric HPV-HIV Protein L1P18 in Pichia pastoris; Purification and Characterization of the Virus-like Particles
- (2021) Yoshiki Eto et al. Pharmaceutics
- Transdermal Vaccination with the Matrix-2 Protein Virus-like Particle (M2e VLP) Induces Immunity in Mice against Influenza A Virus
- (2021) Kimberly Braz Gomes et al. Vaccines
- Sublingual Immunization with Chimeric C1q/CD40 Ligand/HIV Virus-like Particles Induces Strong Mucosal Immune Responses against HIV
- (2021) Dongliang Liu et al. Vaccines
- Development of a SARS-CoV-2 Vaccine Candidate Using Plant-Based Manufacturing and a Tobacco Mosaic Virus-like Nano-Particle
- (2021) Joshua M. Royal et al. Vaccines
- A Novel Double Mosaic Virus-like Particle-Based Vaccine against SARS-CoV-2 Incorporates Both Receptor Binding Motif (RBM) and Fusion Domain
- (2021) Xinyue Chang et al. Vaccines
- Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
- (2020) Chapman et al. Vaccines
- Effect of a Chikungunya Virus–Like Particle Vaccine on Safety and Tolerability Outcomes
- (2020) Grace L. Chen et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Macromolecular modeling and design in Rosetta: recent methods and frameworks
- (2020) Julia Koehler Leman et al. NATURE METHODS
- Influenza Virus Like Particles (VLPs): Opportunities for H7N9 Vaccine Development
- (2020) Peter Pushko et al. Viruses-Basel
- Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles
- (2020) Daning Wang et al. Nature Communications
- Interaction Between Virus-Like Particles (VLPs) and Pattern Recognition Receptors (PRRs) From Dendritic Cells (DCs): Toward Better Engineering of VLPs
- (2020) Jesús Zepeda-Cervantes et al. Frontiers in Immunology
- Efficacy of an intramuscular bivalent norovirus GI.1/GII.4 virus-like particle vaccine candidate in healthy US adults
- (2020) James Sherwood et al. VACCINE
- Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines
- (2020) Chun-Wei Chen et al. Frontiers in Immunology
- Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus
- (2019) Ki-Hye Kim et al. VIROLOGY
- TRIM21—From Intracellular Immunity to Therapy
- (2019) Stian Foss et al. Frontiers in Immunology
- Simultaneous Immunization with Multivalent Norovirus VLPs Induces Better Protective Immune Responses to Norovirus than Sequential Immunization
- (2019) Maria Malm et al. Viruses-Basel
- HPV vaccines: alternative dosage schedules
- (2019) Margaret Stanley Expert Review of Vaccines
- Virus-like Particle-Based L2 Vaccines against HPVs: Where Are We Today?
- (2019) Rashi Yadav et al. Viruses-Basel
- Virus-Like Particle Engineering: From Rational Design to Versatile Applications
- (2018) Xuanwei Ding et al. Biotechnology Journal
- Virus-Like Particle Engineering: From Rational Design to Versatile Applications
- (2018) Xuanwei Ding et al. Biotechnology Journal
- TRIM Proteins and Their Roles in Antiviral Host Defenses
- (2018) Michiel van Gent et al. Annual Review of Virology
- Virus-like particle vaccines: immunology and formulation for clinical translation
- (2018) Braeden Donaldson et al. Expert Review of Vaccines
- Cold chain and virus-free oral polio booster vaccine made in lettuce chloroplasts confers protection against all three poliovirus serotypes
- (2018) Henry Daniell et al. PLANT BIOTECHNOLOGY JOURNAL
- Exploiting virus-like particles as innovative vaccines against emerging viral infections
- (2017) Hotcherl Jeong et al. JOURNAL OF MICROBIOLOGY
- Major findings and recent advances in virus–like particle (VLP)-based vaccines
- (2017) Mona O. Mohsen et al. SEMINARS IN IMMUNOLOGY
- Postmarketing safety surveillance of trivalent recombinant influenza vaccine: Reports to the Vaccine Adverse Event Reporting System
- (2017) Emily Jane Woo et al. VACCINE
- Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets
- (2017) Gale E. Smith et al. VIROLOGY
- A novel H6N1 virus-like particle vaccine induces long-lasting cross-clade antibody immunity against human and avian H6N1 viruses
- (2016) Ji-Rong Yang et al. ANTIVIRAL RESEARCH
- Nonhuman TRIM5 Variants Enhance Recognition of HIV-1-Infected Cells by CD8+T Cells
- (2016) Esther Jimenez-Moyano et al. JOURNAL OF VIROLOGY
- The efficiency of Poly(ADP-Ribose) Polymerase (PARP) cleavage on detection of apoptosis in an experimental model of testicular torsion
- (2015) Pınar Aslan Koşar et al. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY
- A Novel Virus-Like Particle Based Vaccine Platform Displaying the Placental Malaria Antigen VAR2CSA
- (2015) Susan Thrane et al. PLoS One
- Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge
- (2015) Brock Kingstad-Bakke et al. VACCINE
- Ubiquitination in the antiviral immune response
- (2015) Meredith E. Davis et al. VIROLOGY
- Viral chemistry: the chemical functionalization of viral architectures to create new technology
- (2015) Zhuo Chen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus
- (2015) Louis M. Schwartzman et al. mBio
- Age-dependent decrease of anti-HBs titers and effect of booster doses using 2 different vaccines in Palestinian children vaccinated in early childhood
- (2015) Mohammad Qawasmi et al. Human Vaccines & Immunotherapeutics
- Hemagglutinin Sequence Conservation Guided Stem Immunogen Design from Influenza A H3 Subtype
- (2015) V. Vamsee Aditya Mallajosyula et al. Frontiers in Immunology
- Virus-Like Display of a Neo-Self Antigen Reverses B Cell Anergy in a B Cell Receptor Transgenic Mouse Model
- (2014) Bryce Chackerian et al. JOURNAL OF IMMUNOLOGY
- Boosting Immunity to Small Tumor-Associated Carbohydrates with Bacteriophage Qβ Capsids
- (2013) Zhaojun Yin et al. ACS Chemical Biology
- Multiple heterologous M2 extracellular domains presented on virus-like particles confer broader and stronger M2 immunity than live influenza A virus infection
- (2013) Min-Chul Kim et al. ANTIVIRAL RESEARCH
- Tocotrienols promote apoptosis in human breast cancer cells by inducing poly(ADP-ribose) polymerase cleavage and inhibiting nuclear factor kappa-B activity
- (2013) R. Loganathan et al. CELL PROLIFERATION
- Safety of Human Papillomavirus Vaccines: A Review
- (2013) Kristine K. Macartney et al. DRUG SAFETY
- Construction and Characterization of Virus-Like Particles: A Review
- (2012) Andris Zeltins MOLECULAR BIOTECHNOLOGY
- CPMV-DOX Delivers
- (2012) Alaa A. A. Aljabali et al. MOLECULAR PHARMACEUTICS
- Development of AAVLP(HPV16/31L2) Particles as Broadly Protective HPV Vaccine Candidate
- (2012) Karen Nieto et al. PLoS One
- Low-affinity B cells transport viral particles from the lung to the spleen to initiate antibody responses
- (2012) J. Bessa et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus-like particles as a highly efficient vaccine platform: Diversity of targets and production systems and advances in clinical development
- (2012) Natasha Kushnir et al. VACCINE
- Influenza M1 VLPs containing neuraminidase induce heterosubtypic cross-protection
- (2012) Fu-Shi Quan et al. VIROLOGY
- Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic β-cell and the cleavage of poly (ADP-ribose) polymerase
- (2011) Cheol Ryong Ku et al. ENDOCRINE JOURNAL
- Polymeric Dibromomaleimides As Extremely Efficient Disulfide Bridging Bioconjugation and Pegylation Agents
- (2011) Mathew W. Jones et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Influenza Virus-Like Particles Containing M2 Induce Broadly Cross Protective Immunity
- (2011) Jae-Min Song et al. PLoS One
- Gonadotropin-releasing hormone-agonist induces apoptosis of human granulosa-luteal cells via caspase-8, -9 and -3, and poly-(ADP-ribose)-polymerase cleavage
- (2011) Eun Joo Park et al. BioScience Trends
- Activation of caspases and poly (ADP-ribose) polymerase cleavage to induce apoptosis in leukemia HL-60 cells by Inula racemosa
- (2010) Harish Chandra Pal et al. TOXICOLOGY IN VITRO
- Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design
- (2010) Emily M. Plummer et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- A Live Attenuated H1N1 M1 Mutant Provides Broad Cross‐Protection against Influenza A Viruses, Including Highly Pathogenic A/Vietnam/1203/2004, in Mice
- (2009) Hang Xie et al. JOURNAL OF INFECTIOUS DISEASES
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nanotechnology in vaccine delivery
- (2008) Laura J. Peek et al. ADVANCED DRUG DELIVERY REVIEWS
- Aqueous Near-Infrared Fluorescent Composites Based on Apoferritin-Encapsulated PbS Quantum Dots
- (2008) Barbara Hennequin et al. ADVANCED MATERIALS
- Nanoparticles target distinct dendritic cell populations according to their size
- (2008) Vania Manolova et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Alternative binding proteins: Affibody binding proteins developed from a small three-helix bundle scaffold
- (2008) Per-Åke Nygren FEBS Journal
- Evaluation of poly(ADP-ribose) polymerase cleavage (cPARP) in ejaculated human sperm fractions after induction of apoptosis
- (2008) Reda Z. Mahfouz et al. FERTILITY AND STERILITY
- Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood
- (2008) Y. Mikaeloff et al. NEUROLOGY
- Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response
- (2008) Matthew Peacey et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More